GB2333362B - Typing and diagnosis of spongiform encephalopathy - Google Patents

Typing and diagnosis of spongiform encephalopathy

Info

Publication number
GB2333362B
GB2333362B GB9908649A GB9908649A GB2333362B GB 2333362 B GB2333362 B GB 2333362B GB 9908649 A GB9908649 A GB 9908649A GB 9908649 A GB9908649 A GB 9908649A GB 2333362 B GB2333362 B GB 2333362B
Authority
GB
United Kingdom
Prior art keywords
typing
diagnosis
spongiform encephalopathy
spongiform
encephalopathy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9908649A
Other versions
GB2333362A (en
GB9908649D0 (en
Inventor
John Collinge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial College of Science Technology and Medicine
Original Assignee
Imperial College of Science Technology and Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9621469.7A external-priority patent/GB9621469D0/en
Priority claimed from GBGB9621885.4A external-priority patent/GB9621885D0/en
Priority to GB0100890A priority Critical patent/GB2354946B/en
Application filed by Imperial College of Science Technology and Medicine filed Critical Imperial College of Science Technology and Medicine
Priority to GB9908649A priority patent/GB2333362B/en
Priority to GB0101033A priority patent/GB2355074A/en
Priority claimed from PCT/GB1997/002843 external-priority patent/WO1998016834A1/en
Publication of GB9908649D0 publication Critical patent/GB9908649D0/en
Publication of GB2333362A publication Critical patent/GB2333362A/en
Publication of GB2333362B publication Critical patent/GB2333362B/en
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
GB9908649A 1996-10-15 1997-10-15 Typing and diagnosis of spongiform encephalopathy Expired - Fee Related GB2333362B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0101033A GB2355074A (en) 1996-10-15 1997-10-15 Method for predicting susceptibility to bovine spongiform encephalopathy
GB0100890A GB2354946B (en) 1996-10-15 1997-10-15 Means for the treatment of prion disease
GB9908649A GB2333362B (en) 1996-10-15 1997-10-15 Typing and diagnosis of spongiform encephalopathy

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9621469.7A GB9621469D0 (en) 1996-10-15 1996-10-15 Diagnosis
GBGB9621885.4A GB9621885D0 (en) 1996-10-21 1996-10-21 Diagnosis
PCT/GB1997/002843 WO1998016834A1 (en) 1996-10-15 1997-10-15 Diagnosis of spongiform encephalopathy
GB9908649A GB2333362B (en) 1996-10-15 1997-10-15 Typing and diagnosis of spongiform encephalopathy

Publications (3)

Publication Number Publication Date
GB9908649D0 GB9908649D0 (en) 1999-06-09
GB2333362A GB2333362A (en) 1999-07-21
GB2333362B true GB2333362B (en) 2001-05-16

Family

ID=27268522

Family Applications (3)

Application Number Title Priority Date Filing Date
GB9908649A Expired - Fee Related GB2333362B (en) 1996-10-15 1997-10-15 Typing and diagnosis of spongiform encephalopathy
GB0100890A Expired - Fee Related GB2354946B (en) 1996-10-15 1997-10-15 Means for the treatment of prion disease
GB0101033A Withdrawn GB2355074A (en) 1996-10-15 1997-10-15 Method for predicting susceptibility to bovine spongiform encephalopathy

Family Applications After (2)

Application Number Title Priority Date Filing Date
GB0100890A Expired - Fee Related GB2354946B (en) 1996-10-15 1997-10-15 Means for the treatment of prion disease
GB0101033A Withdrawn GB2355074A (en) 1996-10-15 1997-10-15 Method for predicting susceptibility to bovine spongiform encephalopathy

Country Status (1)

Country Link
GB (3) GB2333362B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2611011C (en) 2005-06-08 2014-01-28 Amicus Therapeutics, Inc. Treatment of cns disorders associated with mutations in genes encoding lysosomal enzymes
US7829579B2 (en) 2006-06-23 2010-11-09 Amicus Therapeutics, Inc. Method for the treatment of neurological disorders by enhancing the activity of β-glucocerebrosidase

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892814A (en) * 1987-06-22 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Method for distinguishing Creutzfeldt-Jakob disease from other dementias
GB2258867A (en) * 1991-08-20 1993-02-24 British Tech Group Oligonucleotides and the use thereof in an assay for encephalopathies
WO1996017249A1 (en) * 1994-11-29 1996-06-06 The Minister Of Agriculture, Fisheries And Food In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Spongiform encephalopathy detection methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399567A (en) * 1993-05-13 1995-03-21 Monsanto Company Method of treating cholera
US6054433A (en) * 1994-11-03 2000-04-25 The Regents Of The University Of California Methods and compositions for stimulating tissue growth and epithelial moisturization

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892814A (en) * 1987-06-22 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Method for distinguishing Creutzfeldt-Jakob disease from other dementias
GB2258867A (en) * 1991-08-20 1993-02-24 British Tech Group Oligonucleotides and the use thereof in an assay for encephalopathies
WO1996017249A1 (en) * 1994-11-29 1996-06-06 The Minister Of Agriculture, Fisheries And Food In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Spongiform encephalopathy detection methods

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AMERICAN JOURNAL OF VETERINARY RESEARCH VOL. 53, 1 JUNE 1992PAGES 883-889 *
MOLECULAR NEUROBIOLOGY VOL. 8, -1994 HAMILTON MT USA. PAGES 113-120, *

Also Published As

Publication number Publication date
GB2355074A (en) 2001-04-11
GB2354946B (en) 2001-05-16
GB2333362A (en) 1999-07-21
GB9908649D0 (en) 1999-06-09
GB0101033D0 (en) 2001-02-28
GB0100890D0 (en) 2001-02-21
GB2354946A (en) 2001-04-11

Similar Documents

Publication Publication Date Title
IL133962A0 (en) Combination therapy comprising atorvastatin and an antihypertensive agent
EP1018987A4 (en) Neocartilage and methods of use
GB2326841B (en) Combined thermal and acoustic insulator
ZA945426B (en) Treatment of tachyarrhytmias of supraventricular origin
IL114331A0 (en) Medical use of bromelain
EP0923630A4 (en) Cationic lipids and methods of use therefor
PL341709A1 (en) Structural combination of rubber and metal
HU9602956D0 (en) Porphocyanine and cnc-expanded porphyrins
GB2279546B (en) Combination of saddle and saddle cover
AU2659299A (en) Assembly and attachment of cushions
GB2333362B (en) Typing and diagnosis of spongiform encephalopathy
HUP9800146A3 (en) Thalidomide-derivatives and use of them
GB2308659B (en) Spongiform encephalopathy detection methods
ZA951485B (en) Medical application of bromelain
GB9614615D0 (en) Diagnosis of pre-eclampsia
GB2308658A (en) Spongiform encephalopathy detection methods
GB9424769D0 (en) Spongiform encephalopathy detection methods
GB9424768D0 (en) Spongiform encephalopathy detection methods
EP1015559A4 (en) Human regeneration-associated serpin-1 (rasp-1) and methods of use
GB9717848D0 (en) Fixing and methods of assembly
SI1009400T1 (en) Combination therapy comprising atorvastatin and an antihypertensive agent
PL338862A1 (en) Derivatives of 2-oxypyroimidin-4-one and 2-oxypyroimidin-4-thione
TW308897U (en) Handle and its connection structure of bicycle
GB9506378D0 (en) Catalyst composition and use therefor
EG21357A (en) Alarm against thief of stalliet components

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20151015